Browsing Tag
Switzerland
88 posts
Ferring, Blackstone invest $570m in nadofaragene firadenovec gene therapy
Ferring Pharmaceuticals, a Swiss specialty biopharmaceutical group, has teamed up with private investment platform Blackstone Life Sciences to…
November 26, 2019
SIX Group offers to buy Spanish stock exchange company BME for €2.84bn
SIX Group, a Swiss financial services company, has proposed to acquire 100% of Spanish stock exchange company Bolsas…
November 22, 2019
Dicerna, Roche strike $1.67bn deal for hepatitis B virus therapies
Dicerna Pharmaceuticals has secured a research collaboration and licensing deal worth up to $1.67 billion with Roche to…
November 2, 2019
Galderma launches phase 3 atopic dermatitis trial for nemolizumab
Galderma, a Nestle-owned Swiss pharma company, said that it has enrolled the first patients in a phase 3…
October 11, 2019
Aryzta to sell 43% stake in French frozen food producer Picard
Swiss food company Aryzta has been given a binding offer from Tunisian investment group Invest Group Zouari (IGZ)…
October 8, 2019
Temenos to acquire Kony to advance digital front office product Temenos Infinity
Temenos acquisition of Kony : Temenos, a Swiss banking software company, has agreed to acquire Kony, a US-based…
August 29, 2019
Boehringer Ingelheim acquires Swiss biotech company AMAL Therapeutics
Boehringer Ingelheim acquisition of AMAL Therapeutics : German pharma company Boehringer Ingelheim has acquired Swiss biotech company AMAL…
July 16, 2019
Pfizer wraps up $810m acquisition of Swiss biotech company Therachon
Pfizer acquisition of Therachon : US pharma giant Pfizer has completed its previously announced acquisition of Swiss biotech…
July 7, 2019
Medical Properties Trust acquires stake in Switzertland’s Infracore
US-based real estate investment trust Medical Properties Trust (MPT) has acquired a 46% stake in Swiss healthcare real…
June 9, 2019
Swiss pharma Orphan Technologies launches phase 1/2 clinical trial for OT-58 in classical homocystinuria
Orphan Technologies, a Swiss pharmaceutical company, has officially dosed the first patients in its groundbreaking phase 1/2 clinical…
February 16, 2019